BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 15934883)

  • 1. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy.
    Léger JM
    Expert Opin Pharmacother; 2005 Apr; 6(4):569-82. PubMed ID: 15934883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Guimarães-Costa R; Iancu Ferfoglia R; Viala K; Léger JM
    Rev Neurol (Paris); 2014 Oct; 170(10):595-601. PubMed ID: 25200479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
    Iijima M
    Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research criteria for defining patients with CIDP.
    Sander HW; Latov N
    Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
    Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
    Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of chronic inflammatory demyelinating polyneuropathy.
    Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
    J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
    Kuwabara S
    Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic dysimmune polyneuropathies.
    Léger JM
    Transfus Sci; 1999 Feb; 20(1):63-7. PubMed ID: 10621562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of CIDP and related immune-mediated neuropathies.
    Koski CL
    Neurology; 2002 Dec; 59(12 Suppl 6):S22-7. PubMed ID: 12499467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
    Dalakas MC
    J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy.
    Nicolas G; Maisonobe T; Le Forestier N; Léger JM; Bouche P
    Muscle Nerve; 2002 Jan; 25(1):26-30. PubMed ID: 11754181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
    Eftimov F; van Schaik I
    Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    Bright RJ; Wilkinson J; Coventry BJ
    BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.